基因技术工具 · 全部实体（第 25 / 100 页）

本页收录第 2401–2500 条，共 10000 条 · 返回 基因技术工具 首页

• CRISPR-Cas9: Engineering a revolution in gene editing
  The CRISPR-Cas9 system is revolutionizing genomic engineering and equipping scientists with the ability to precisely modify the DNA of essentially any organism. Just how powerful is this technique? The ability for precision genome engineering comes with the po…
  crossref 2021-10-11T13:45:44Z 置信度 0.70
• Bioinformatics Approaches for Gene Editing Technologies like CRISPR
  Gene editing technologies, particularly CRISPR-Cas9, have revolutionized genetic research and therapeutic development by allowing precise modifications to DNA. Bioinformatics approaches play a critical role in optimizing gene editing by predicting target sites…
  crossref Dr. David Johnson 2026-03-30T05:54:59Z 置信度 0.70
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Proteins (Cas) [CRISPR–Cas]: An Emerging Technique in Plant Disease Detection and Management
  crossref Swapan Kumar Ghosh, Tuhin Chatterjee 2024-03-18T08:02:35Z 置信度 0.70
• Multiple Lignocellulosic Inhibitor-Tolerant Saccharomyces cerevisiae Strains Developed by Evolutionary Engineering and CRISPR/Cas9 Gene Editing Technology
  crossref 2025-09-04T10:50:16Z 置信度 0.70
• Research progress of gene editing technology CRISPR/Cas9 system in animal gene editing
  crossref F Fan, K Mengna, Z Xiaolan, C Weiping 等 2018-08-09T06:44:00Z 置信度 0.70
• Germline gene editing with CRISPR
  crossref Siddharta B. Chiong, Nicanor Austriaco 2023-06-12T15:50:51Z 置信度 0.70
• Gene Editing: CRISPR and Beyond
  Gene editing technologies, particularly CRISPR, have significantly transformed fields such as medicine, agriculture, and biotechnology, offering precise modifications to DNA with increasing efficiency and lower costs. This review highlights CRISPR’s significan…
  crossref Mary Christine Wheatley 2025-05-09T23:10:37Z 置信度 0.70
• Site-Specific and Enzymatic Cross-Linking of sgRNA Enables Wavelength-Selectable Photoactivated Control of CRISPR Gene Editing
  crossref 2022-03-08T06:25:43Z 置信度 0.70
• Application of Genome Editing for Improving Nematode Resistance in Plants: How far we have progressed?
  crossref Tushar K. Dutta 2024-03-18T08:02:35Z 置信度 0.70
• CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application
  crossref Bastian Minkenberg, Matthew Wheatley, Yinong Yang 2017-06-20T21:46:56Z 置信度 0.70
• CRISPR Technologies for In Vivo and Ex Vivo Gene Editing
  What Is the Issue? The first therapeutics based on clustered regularly interspaced short palindromic repeats (CRISPR) technologies are entering the market. These gene-editing technologies have the potential to change treatment paradigms and may be used to trea…
  crossref CDA-AMC 2024-10-17T11:52:22Z 置信度 0.70
• Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System
  crossref 2020-11-11T08:25:11Z 置信度 0.70
• CRISPR-Cas genome-editing tool in plant abiotic stress-tolerance
  crossref Dew Biswas, Suchismita Chatterjee Saha, Abhijit Dey 2021-03-19T10:54:09Z 置信度 0.70
• Manipulating the CRISPR/Cas Genome Editing Technology for Targeted Genome Mutagenesis in Ornamental Plants
  crossref Irum Saadia Khan, Khurram Shahzad, Fahim Ullah Khan, Abdul Basit 等 2026-04-01T14:14:25Z 置信度 0.70
• The scope and challenges of visualizing CRISPR-Cas9 gene editing in real time
  crossref Krishanu Saha 2017-05-10T14:56:53Z 置信度 0.70
• CRISPR-Cas9-Mediated Gene Editing in Wheat: A Step-by-Step Protocol
  crossref Pankaj K. Bhowmik, M. Tofazzal Islam 2020-06-30T01:16:58Z 置信度 0.70
• CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing
  crossref 2021-02-18T01:03:06Z 置信度 0.70
• CRISPR/Cas9-Based Genome Editing in Plants
  crossref Yaling Zhang, Xingliang Ma, Xianrong Xie, Yao-Guang Liu 2017-05-12T13:31:32Z 置信度 0.70
• CRISPR-Cas and Its Applications in Food Production
  crossref Nitish Rai, Namita Ashish Singh, Juhi Goyal, Priyank Upadhayay 等 2024-03-18T08:02:35Z 置信度 0.70
• ENCSR429MST
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR612JXK
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR629NUQ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR966HHU
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR961SJX
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR522VAZ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR178RVM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR890HZD
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR127JDF
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR529POX
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR008UZG
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR781IDA
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• Spotlight Therapeutics raises $30 million in vivo CRISPR gene editing
  crossref Ryan Cross 2020-12-07T06:30:14Z 置信度 0.70
• ENCSR606NBL
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR250LQB
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR241PEK
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR994VHG
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR107CWG
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR562NZE
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR911GHJ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR517QLP
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR043MAQ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR040SYA
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR936TZP
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR555AEQ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR702HJT
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR108XUL
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR840OSW
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR112CSN
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR959WAF
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• CRISPR-Cas9-Mediated Gene Editing of the Plant Pathogenic Oomycete Phytophthora palmivora
  crossref Miaoying Tian, Natasha Navet, Dongliang Wu 2020-06-30T01:16:58Z 置信度 0.70
• Agri-Biotechnology and the Failed Promises of the Seed- Chemical Complex, CRISPR and Gene Editing, and Regulatory Capture
  This chapter traces the consolidation of power over the global seed-chemical complex by an elite group of ‘legacy’ life science corporations and the parallel privatisation of agricultural R&D. These developments reinforce the industrial agro-food system, r…
  crossref David Goodman 2024-01-22T11:56:09Z 置信度 0.70
• ENCSR271VMA
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR269CKX
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR506QBE
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR254YPW
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR172JHG
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR340GYM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR987PLV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR342TEI
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR884ELU
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR455YLP
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR227MBD
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• CRISPR-Based Approach: A Way Forward to Sustainable Development Goals (SDGs)
  crossref Kritika Shah, Amanpreet Kaur, Sonika Saxena, Sudipti Arora 2024-03-18T04:02:35Z 置信度 0.70
• CRISPR/Cas9 Gene Editing: An Approach to Prevent Hereditary Cancers
  Mutations in oncogenes and tumor-suppressor genes can give rise to a variety of genetic cancers. The use of CRISPR/Cas9 can be applicable in the prevention of these cancers through the knockout of oncogenes and the upregulation of tumor-suppressor genes. This …
  crossref Cayla McKay 2024-08-11T22:17:01Z 置信度 0.70
• ENCSR469JJP
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR916GJJ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR414EQZ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR787FNM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR713SJV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR927AOM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR940ASR
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR312QIX
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR608EQY
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR820HUT
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR495FVC
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR258RES
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR409VAG
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• CRISPR-Cas9 Gene Editing for β-Hemoglobinopathies Therapy
  β-hemoglobinopathies, comprising sickle cell disease (SCD) and transfusion -dependent β-thalassemia (TDT), represent monogenetic disorders caused by mutations in the β-globin gene, resulting in aberrant hemoglobin synthesis and severe clinical complications. C…
  crossref Junzhe Zheng 2025-07-20T13:01:25Z 置信度 0.70
• ENCSR665JUV
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• The CRISPR-Cas12a Platform for Accurate Genome Editing Gene Disruption, and Efficient Transgene Integration in Human Immune Cells
  crossref 2023-02-07T19:50:10Z 置信度 0.70
• CRISPR-based metabolic editing: Next-generation metabolic engineering in plants
  crossref Mohammad Sabzehzari, Masoumeh Zeinali, Mohammad Reza Naghavi 2020-07-24T11:47:33Z 置信度 0.70
• ENCSR425FXE
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR097WOJ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR863PXE
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR837ZEJ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR049SQV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR883RLC
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR871SAO
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR163IXP
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR980ERC
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR858ONP
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• Tomatoes made with CRISPR gene editing go on sale
  crossref Michael Le Page 2021-10-02T02:29:37Z 置信度 0.70
• ENCSR989JZM
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR872LJT
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR180AST
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR326WWQ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR662PKM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1
  Allergy to domestic cat affects up to 15% of the population, and sensitization to cat allergen is associated with asthma. Despite the pervasiveness of cat allergic disease, current treatments have limited impact. Here, we present a bioinformatics analysis of t…
  crossref Nicole F. Brackett, Brian W. Davis, Mazhar Adli, Anna Pomés 等 2022-03-28T09:51:07Z 置信度 0.70
• ENCSR372KFL
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR707SEA
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70